Summary
- Current Price
- As of today, SOLV price is $86.82, down -1.95% on
- Current Price All-Time High
- SOLV price is currently -2.06% below its historical high of $88.65 set on
- Market Cap
- SOLV current market cap is $15B, up +21.52% over the past 365 days
- PE Ratio
- SOLV current PE ratio is 10.63
- Revenue
- SOLV current annual revenue is $8.33B, up +0.86% year-over-year
- Next Earnings
- The next earnings release for SOLV is on
Profile
| Metric | Value |
|---|---|
| Full Name | Solventum Corporation |
| Ticker | NYSE: SOLV |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | |
| Website | solventum.com |
| Employees | 22,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $86.82 | |
| Price, 1D Change | -1.95% | |
| Market Cap | $15B | |
| - | ||
| PE Ratio | 10.63 | |
| Beta | 0.65 | |
| Revenue | $8B | |
| Revenue, 1Y Change | +0.86% | |
| EPS | $8.88 | |
| EPS, 1Y Change | +221.88% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | SOLV.V | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $8.88 | |
| EPS Estimate | N/A | $6.55 |
| EPS Est. Change | N/A | -26.20% |
| Revenue | $8.33B | |
| Revenue Estimate | N/A | $8.20B |
| Revenue Est. Change | N/A | -1.52% |
| Current Price | $86.82 | |
| Price Target | - | $85.00 |
| Price Tgt. Change | - | -2.10% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $6.57 | $2.76 | -58.00% | |
| $6.02 | $8.88 | +47.36% | |
| $6.55 | N/A | -26.20% | |
| $7.09 | N/A | -20.16% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.23B | $8.25B | +0.28% | |
| $8.27B | $8.33B | +0.63% | |
| $8.20B | N/A | -1.52% | |
| $8.48B | N/A | +1.89% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +21.66% | |
| Price, 3Y | - | |
| Market Cap, 1Y | +21.52% | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | +0.86% | |
| Revenue, 3Y | +2.40% | |
| EPS, 1Y | +221.88% | |
| EPS, 3Y | +14.15% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $86.82 | |
| SMA 200 | $75.19 | |
| SMA 50 | $78.15 | |
| EMA 200 | $74.83 | |
| EMA 50 | $77.90 | |
| MACD | $2.13 | |
| Beta | 0.65 | |
| ATR | $2.56 | |
| 14-Day RSI | 66.61 | |
| 10-Day Volatility | 46.54% | |
| 1-Year Volatility | 29.69% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $8.33B | |
| EPS | $8.88 | |
| Gross Profit | $0.00 | |
| Gross Margin | 53.59% | |
| Operating Income | $719.00M | |
| Operating Margin | 8.64% | |
| Net Income | $1.56B | |
| Net Margin | 18.69% | |
| EBITDA | $1.21B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.04 | |
| 1.23 | ||
| 0.89 | ||
| - | ||
| 6 | ||
| 1.79 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 10.63 | |
| 1.81 | ||
| 3.03 | ||
| 13.55 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $5.05B | |
| $878.00M | ||
| $14.29B | ||
| $3.86B | ||
| $9.25B | ||
| $3.14B | ||
| Total Debt | $5.25B | |
| $70.00M | ||
| $687.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $6.77B | ||
| $3.74B | ||
| $3.86B | ||
| $3.08B | ||
| $489.00M | ||
| $0.00 | ||
| $157.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $369.00M | ||
| $2.80B | ||
| -$3.06B | ||
| Capex | $379.00M | |
| -$10.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| BMO Capital | ||
| Wedbush | ||
| Wells Fargo | → | |
| UBS | → | |
| Stifel | → | |
| Keybanc | → | |
| BTIG | → | |
| Keybanc | → | |
| Piper Sandler | → | |
| Rothschild & Co |
Analyst sentiment
Institutional ownership
Screeners with SOLV
FAQ
What is the ticker symbol for Solventum Corporation?
The ticker symbol for Solventum Corporation is NYSE:SOLV
Does Solventum Corporation pay dividends?
No, Solventum Corporation does not pay dividends
What sector is Solventum Corporation in?
Solventum Corporation is in the Healthcare sector
What industry is Solventum Corporation in?
Solventum Corporation is in the Medical Instruments & Supplies industry
What country is Solventum Corporation based in?
Solventum Corporation is headquartered in United States
When did Solventum Corporation go public?
Solventum Corporation initial public offering (IPO) was on April 1, 2024
Is Solventum Corporation in the S&P 500?
Yes, Solventum Corporation is included in the S&P 500 index
Is Solventum Corporation in the NASDAQ 100?
No, Solventum Corporation is not included in the NASDAQ 100 index
Is Solventum Corporation in the Dow Jones?
No, Solventum Corporation is not included in the Dow Jones index
When was Solventum Corporation last earnings report?
Solventum Corporation's most recent earnings report was on May 5, 2026
When does Solventum Corporation report earnings?
The next expected earnings date for Solventum Corporation is August 5, 2026
Data Sources & References
- SOLV Official Website www.solventum.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1964738/000196473826000007/0001964738-26-000007-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- SOLV Profile on Yahoo Finance finance.yahoo.com/quote/SOLV
- SOLV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/solv